Lates News

Pfizer's statement on Tuesday said the FDA has notified that it may not extend its long-term emergency use authorization for children aged 6 months to 4 years. Pfizer said it has applied to maintain this authorization in the upcoming fall and winter seasons and is "discussing potential solutions with the FDA."